Bruno Märkl Selected Research

Bruno Märkl Research Topics

Disease

34	Neoplasms (Cancer) 02/2024 - 03/2010
14	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 07/2007
10	Colonic Neoplasms (Colon Cancer) 12/2023 - 12/2008
8	Stomach Neoplasms (Stomach Cancer) 11/2023 - 03/2009
7	COVID-19 01/2023 - 01/2021
5	Neoplasm Metastasis (Metastasis) 08/2021 - 03/2010
3	Infections 04/2024 - 08/2011
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2024 - 10/2010
3	Lymphatic Metastasis 11/2023 - 09/2013
3	Adenocarcinoma 09/2021 - 04/2021
3	Carcinoma (Carcinomatosis) 12/2020 - 04/2017
3	Sarcoma (Soft Tissue Sarcoma) 09/2018 - 02/2016
3	Rectal Neoplasms (Rectal Cancer) 05/2009 - 07/2007
2	Disease Progression 04/2024 - 07/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2003
2	Lymphoma (Lymphomas) 01/2023 - 11/2019
2	Immunoglobulin G4-Related Disease 11/2019 - 01/2011
2	Breast Neoplasms (Breast Cancer) 07/2019 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 08/2018 - 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 12/2024
1	Neuroendocrine Carcinoma 02/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2022
1	Superinfection 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Cough 09/2020
1	Dyspnea (Shortness of Breath) 09/2020
1	Multiple Sclerosis 09/2020
1	Autoimmune Pancreatitis 11/2019
1	Lymphadenopathy 11/2019
1	Stomach Ulcer (Gastric Ulcer) 11/2019
1	Barrett Esophagus (Barrett's Esophagus) 01/2019
1	Ulcer 01/2019
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019
1	Acinar Cell Carcinoma 01/2019
1	Pathologic Constriction (Stenosis) 01/2019
1	Tuberous Sclerosis (Bourneville's Disease) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Hyperplasia 01/2018
1	Myopericytoma 02/2017
1	Angiomyoma (Angioleiomyoma) 02/2017

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2017
8	Keratins (Keratin)IBA 04/2021 - 07/2013
8	Methylene Blue (Methylthioninium Chloride)FDA Link 05/2016 - 07/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
3	SteroidsIBA 12/2024 - 08/2011
3	Transcription Factors (Transcription Factor)IBA 02/2024 - 01/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 11/2023
2	Hematoxylin (Haematoxylon)IBA 01/2024 - 11/2023
2	Indicators and Reagents (Reagents)IBA 11/2023 - 09/2021
2	LectinsIBA 01/2023 - 01/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 11/2019
2	Immunoglobulin G (IgG)IBA 11/2019 - 01/2011
2	Plasminogen Activator Inhibitor 1IBA 07/2019 - 01/2017
2	Peptide Hydrolases (Proteases)FDA Link 07/2019 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 09/2018 - 01/2016
2	MART-1 AntigenIBA 02/2016 - 01/2013
1	Glial Fibrillary Acidic ProteinIBA 12/2024
1	CalciumIBA 12/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 03/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 03/2023
1	Calcibiotic Root Canal SealerIBA 02/2023
1	COVID-19 VaccinesIBA 01/2023
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2022
1	Cortisone FDA Link 01/2022
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	VaccinesIBA 01/2022
1	Complement Factor D (Factor D)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	CollagenIBA 10/2021
1	tyramine-deoxysorbitolIBA 08/2021
1	Nucleic AcidsIBA 05/2021
1	Viral RNAIBA 03/2021
1	rovalpituzumab tesirineIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	delta proteinIBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Alemtuzumab (Campath)FDA Link 09/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	Member 3 Group A Nuclear Receptor Subfamily 4IBA 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019
1	Prednisolone (Predate)FDA LinkGeneric 01/2019
1	lipoarabinomannan (LAM)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018
1	Bevacizumab (Avastin)FDA Link 09/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	vandetanib (ZD6474)IBA 01/2018

Therapy/Procedure

18	Therapeutics 04/2024 - 07/2007
6	Lymph Node Excision (Lymph Node Dissection) 05/2016 - 02/2003
5	Drug Therapy (Chemotherapy) 12/2023 - 07/2010
2	Immunotherapy 01/2023 - 03/2019
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2018 - 01/2018
1	Neoadjuvant Therapy 01/2023
1	Personal Protective Equipment 03/2022
1	Radiotherapy 05/2017